Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of November 17, 2026, THC trades at $288.15 with a market cap of $22.76B and a P/E ratio of 16.53. THC moved -1.16% today. Year to date, THC is +46.33%; over the trailing twelve months it is +51.29%. Its 52-week range spans $109.82 to $301.44. Analyst consensus is strong buy with an average price target of $308.27. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tenet raises FY26 EBITDA outlook by $195 million; transition contributions won’t recur in 2027: Tenet raised FY26 adjusted EBITDA guidance by $195 million to $5.05 billion–$5.2 billion and adjusted free cash flow guidance to $1.93 billion–$2.16 billion. Q3 adjusted EBITDA rose 23.3% to $1.36 billion, including $147 million in favorable transition impacts; transition activities are expected to contribute approximately $450 million to full-year adjusted EBITDA, with no such contributions expected to recur in 2027.
| Metric | Value |
|---|---|
| Price | $288.15 |
| Market Cap | $22.76B |
| P/E Ratio | 16.53 |
| EPS | $15.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $301.44 |
| 52-Week Low | $109.82 |
| Volume | 107 |
| Avg Volume | 0 |
| Revenue (TTM) | $21.31B |
| Net Income | $2.37B |
| Gross Margin | 0.00% |
16 analysts cover THC: 0 strong buy, 14 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $308.27.